Gilead Sciences to Release Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 4, 2021 Biotech Investing
Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Biotech Investing
Bristol Myers Squibb Announces Earnings Call Time Change; Fourth Quarter 2020 Earnings Call to Occur on February 4, 2021 at 10 a.m. Biotech Investing
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip Device Medical Device Investing
Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium Medical Device Investing
U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction Cancer Biotech Investing
U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma Biotech Investing
